Brazil’s IVD sector invited to table industry evidence for patient safety project
This article was originally published in Clinica
Executive Summary
Brazil’s in vitro diagnostic and laboratory supplies industry association, CBDL, has called on its members to help it collate feedback for a prospective government consultation on improving safety and service quality. CBDL has asked its members to submit feedback on three questions posed by healthcare products regulatory agency Anvisa: how can the CBDL contribute to the introduction of a national healthcare safety project; does such a project pose any risk or “negative impacts”; and are there any patient safety initiatives already in place? The CBDL is to participate in parliamentary discussions on the matter and is being invited to table details of specific patient safety initiatives already under way.
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.